MIRMirion Technologies, Inc.

NYSE mirion.com


$ 11.09 $ 0.08 (0.73 %)    

Friday, 26-Apr-2024 15:59:56 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 11.09
$ 11.05
$ 0.00 x 0
$ 0.00 x 0
$ 11.00 - $ 11.09
$ 6.70 - $ 11.50
714,570
na
2.18B
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 07-29-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-28-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 citigroup-maintains-buy-on-mirion-technologies-raises-price-target-to-14

Citigroup analyst Andrew Kaplowitz maintains Mirion Technologies (NYSE:MIR) with a Buy and raises the price target from $13 ...

 mirion-technologies-q4-2023-adj-eps-015-beats-014-estimate-sales-23040m-beat-21888m-estimate

Mirion Technologies (NYSE:MIR) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.1...

 earnings-scheduled-for-february-13-2024

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on reven...

 citigroup-maintains-buy-on-mirion-technologies-raises-price-target-to-12

Citigroup analyst Andrew Kaplowitz maintains Mirion Technologies (NYSE:MIR) with a Buy and raises the price target from $11 ...

 mirion-technologies-signs-agreement-with-terrapower-for-molten-chloride-reactor-experiment

Contract to provide Nuclear Instrumentation System Design and Fabrication that will Advance the World's First Critical Fast...

 mirion-technologies-q3-2023-adj-eps-005-up-from-003-yoy-sales-19120m-up-from-16090m-yoy

Mirion Technologies (NYSE:MIR) reported quarterly earnings of $0.05 per share. This is a 66.67 percent increase over earnings o...

 earnings-scheduled-for-november-1-2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of...

 mirion-technologies-gamma-detector-to-play-crucial-role-in-nasas-psyche-mission

High-Purity Germanium Detector Will Provide Key Insights into the Make-Up of the Metallic AsteroidMirion Technologies (NYSE:MIR...

 mirion-medical-announced-attaining-ce-mark-per-eu-medical-device-regulation-for-the-sunscan-3d-cylindrical-water-scanning-system

MELBOURNE, Fla., Sept. 28, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), today announced achievement o...

 mirion-technologies-awarded-strategic-design-contract-for-x-energys-small-modular-reactor

Agreement Focused on Unique Burn Up Measurement System (BUMS) in Development of the Xe-100 High-Temperature Gas-Cooled Reactor ...

 earnings-scheduled-for-august-2-2023

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earn...

 mirrion-sees-fy23-eps-028-034-vs-031-est-revenue-growth-of-8-10-compared-to-6-9-previously

Updated 2023 Outlook "Top-line performance was very strong in the first half and we expect to see continued momentum throu...

 mirion-technologies-q2-eps-008-beats-006-estimate-sales-19720m-beat-19049m-estimate

Mirion Technologies (NYSE:MIR) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.0...

 citigroup-reinstates-buy-on-mirion-technologies-announces-11-price-target

Citigroup analyst Andrew Kaplowitz reinstates Mirion Technologies (NYSE:MIR) with a Buy and announces $11 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION